Find information on thousands of medical conditions and prescription drugs.

Common cold

The common cold (also known as "acute nasopharyngitis") is a mild viral infectious disease of the nose and throat; the upper respiratory system. Symptoms include sneezing, sniffling, running/blocked nose (often these occur simultaneously, or in only one nostril); scratchy, sore, or phlegmy throat; coughing; headache; and tiredness. Colds typically last three to five days, with residual coughing lasting up to three weeks. As its name suggests, it is the most common of all human diseases, infecting subjects at an average rate of slightly over one infection per year per person. Infection rates greater than three infections per year per person are not uncommon in some populations. more...

Home
Diseases
A
B
C
Angioedema
C syndrome
Cacophobia
Café au lait spot
Calcinosis cutis
Calculi
Campylobacter
Canavan leukodystrophy
Cancer
Candidiasis
Canga's bead symptom
Canine distemper
Carcinoid syndrome
Carcinoma, squamous cell
Carcinophobia
Cardiac arrest
Cardiofaciocutaneous...
Cardiomyopathy
Cardiophobia
Cardiospasm
Carnitine transporter...
Carnitine-acylcarnitine...
Caroli disease
Carotenemia
Carpal tunnel syndrome
Carpenter syndrome
Cartilage-hair hypoplasia
Castleman's disease
Cat-scratch disease
CATCH 22 syndrome
Causalgia
Cayler syndrome
CCHS
CDG syndrome
CDG syndrome type 1A
Celiac sprue
Cenani Lenz syndactylism
Ceramidase deficiency
Cerebellar ataxia
Cerebellar hypoplasia
Cerebral amyloid angiopathy
Cerebral aneurysm
Cerebral cavernous...
Cerebral gigantism
Cerebral palsy
Cerebral thrombosis
Ceroid lipofuscinois,...
Cervical cancer
Chagas disease
Chalazion
Chancroid
Charcot disease
Charcot-Marie-Tooth disease
CHARGE Association
Chediak-Higashi syndrome
Chemodectoma
Cherubism
Chickenpox
Chikungunya
Childhood disintegrative...
Chionophobia
Chlamydia
Chlamydia trachomatis
Cholangiocarcinoma
Cholecystitis
Cholelithiasis
Cholera
Cholestasis
Cholesterol pneumonia
Chondrocalcinosis
Chondrodystrophy
Chondromalacia
Chondrosarcoma
Chorea (disease)
Chorea acanthocytosis
Choriocarcinoma
Chorioretinitis
Choroid plexus cyst
Christmas disease
Chromhidrosis
Chromophobia
Chromosome 15q, partial...
Chromosome 15q, trisomy
Chromosome 22,...
Chronic fatigue immune...
Chronic fatigue syndrome
Chronic granulomatous...
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic obstructive...
Chronic renal failure
Churg-Strauss syndrome
Ciguatera fish poisoning
Cinchonism
Citrullinemia
Cleft lip
Cleft palate
Climacophobia
Clinophobia
Cloacal exstrophy
Clubfoot
Cluster headache
Coccidioidomycosis
Cockayne's syndrome
Coffin-Lowry syndrome
Colitis
Color blindness
Colorado tick fever
Combined hyperlipidemia,...
Common cold
Common variable...
Compartment syndrome
Conductive hearing loss
Condyloma
Condyloma acuminatum
Cone dystrophy
Congenital adrenal...
Congenital afibrinogenemia
Congenital diaphragmatic...
Congenital erythropoietic...
Congenital facial diplegia
Congenital hypothyroidism
Congenital ichthyosis
Congenital syphilis
Congenital toxoplasmosis
Congestive heart disease
Conjunctivitis
Conn's syndrome
Constitutional growth delay
Conversion disorder
Coprophobia
Coproporhyria
Cor pulmonale
Cor triatriatum
Cornelia de Lange syndrome
Coronary heart disease
Cortical dysplasia
Corticobasal degeneration
Costello syndrome
Costochondritis
Cowpox
Craniodiaphyseal dysplasia
Craniofacial dysostosis
Craniostenosis
Craniosynostosis
CREST syndrome
Cretinism
Creutzfeldt-Jakob disease
Cri du chat
Cri du chat
Crohn's disease
Croup
Crouzon syndrome
Crouzonodermoskeletal...
Crow-Fukase syndrome
Cryoglobulinemia
Cryophobia
Cryptococcosis
Crystallophobia
Cushing's syndrome
Cutaneous larva migrans
Cutis verticis gyrata
Cyclic neutropenia
Cyclic vomiting syndrome
Cystic fibrosis
Cystinosis
Cystinuria
Cytomegalovirus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Children and their caretakers are at a higher risk, probably due to the high population density of schools and the fact that transmission to family members is highly efficient.

The common cold belongs to the upper respiratory tract infections. It is different from influenza, a more severe viral infection of the respiratory tract that shows the additional symptoms of rapidly rising fever, chills, and body and muscle aches. While the common cold itself is hardly life threatening, its complications, such as pneumonia, can very well be.

Pathology

The common cold is caused by numerous viruses (mainly rhinoviruses, coronaviruses, and also certain echoviruses, paramyxoviruses, and coxsackieviruses) infecting the upper respiratory system. Several hundred cold-causing viruses have been described, and a virus can mutate to survive, ensuring that any cure is still a long way off. The viruses are transmitted from person to person by droplets resulting from coughs or sneezes. The droplets or droplet nuclei are either inhaled directly, or transmitted from hand to hand via handshakes or objects such as door knobs, and then introduced to the nasal passages when the hand touches the nose or eyes.

The virus enters the cells of the lining of the nasopharynx (the area between the nose and throat), and rapidly multiplies. The major entry points are the nose and eyes, through the nasolacrymal duct drainage into the nasopharynx. The mouth is not a major point of entry and transmission does not usually occur with kissing or swallowing. The nasopharynx is the central area infected. The reasons that the virus concentrates in the nasopharynx rather than the throat may be the low temperature and high concentration of cells with receptors needed by the virus.

The virus enters the cell by binding to ICAM-1 receptors in these cells. The presence of ICAM-1 affects whether a cell will be infected. Its concentration also can be affected by various other factors, including allergic rhinitis and some other irritants including rhinoviruses themselves. ICAM-1 has been a major focal point in drug research into cold treatments.

"Cold" as misnomer

The term "cold" (as it relates to climatic temperature) is somewhat misleading. Climate may affect transmission by some means, such as by causing people to stay indoors and increasing the proximity to infected persons, but the cause of the infection remains viral. Some allergies, bacterial respiratory infections, and even climate changes can also cause common-cold-like symptoms that can last for days.

It is not definitely known whether cold weather or a humid climate can affect transmission by other means, such as by affecting the immune system, or ICAM-1 receptor concentration, or simply increasing the amount and frequency of nasal secretions and frequency of hand to face contact. A person can best avoid colds by avoiding those who are ill and the objects that they touch, as well as by keeping their immune system in top form by getting enough sleep, reducing stress, eating nutritious foods, and avoiding excess alcohol consumption. However, researchers at the Common Cold Centre at the University of Cardiff recently demonstrated that cold temperatures can lead to a greater susceptibility to viral infection. They showed that a group of people who sat with their feet in cold water for 20 minutes a day for a week had a 1 in 3 chance of developing cold symptoms during that week, while a control group who sat with their feet in an empty bowl had a 1 in 10 chance. It is thought this may be due to cold temperatures reducing blood circulation needed to carry white blood cells to the area of infection.

Read more at Wikipedia.org


[List your site here Free!]


Echinacea disappoints: there's still no cure for the common cold
From Science News, 7/30/05 by N. Seppa

A folk remedy touted as a cold treatment has failed its most recent--and possibly most exacting--test. Volunteers exposed to a cold virus and given the herbal supplement echinacea fared no better than did virus-exposed participants who received an inert substance, researchers report in the July 28 New England Journal of Medicine.

The U.S. study is the third in 3 years in which echinacea failed to alleviate colds in children or, as in this case, young adults. These findings run counter to earlier reports, most out of Europe, that echinacea revs up an immune response against cold viruses (SN: 3/27/99, p. 207).

For the new study, researchers recruited 399 young adults. Some received drops of Echinacea angustifolia extract and others got placebos. After a week, all volunteers received nasal sprays containing rhinovirus type 39, a common cold virus, and were sequestered in a hotel room for 5 days.

After exposure, volunteers getting echinacea continued to take it. Some participants getting the placebos were switched to echinacea, while others continued with the placebos.

None of it mattered, says study coauthor Ronald B. Turner of the University of Virginia in Charlottesville. More than 80 percent of the people in each group became infected with the virus, and roughly three-fifths of each group showed cold symptoms within a week. The severity of the symptoms also was the same across the groups.

Furthermore, blood tests showed no significant immune boost from echinacea.

While this study tested only E. angustifolia, there is considerable overlap in the chemical constituents of the three purple cone-flower species from which echinacea is derived, says Benjamin Kligler of the Albert Einstein College of Medicine in New York.

Therefore, the new study's findings "might apply to the other Echinacea species as well," says herbal medicine specialist Wallace Sampson of Stanford University.

Echinacea formulations often contain more than one species of the plant (SN: 6/7/03, p. 359). Since the preparations are sold as dietary supplements and not drugs, the Food and Drug Administration doesn't regulate their effectiveness or content.

"Three big negative trials have now come out," says Bruce P. Barrett of the University of Wisconsin-Madison. In the study that he led, reported in 2002, college students with colds fared the same whether they got placebos or a mix of the Echinacea species. In a 2003 report, researchers at the University of Washington in Seattle found that Echinacea purpurea, a common ingredient in formulations, was no weapon against colds in children.

Barrett and Kligler, both physicians, say that they wouldn't discourage people currently using echinacea from continuing to do so, because the supplement is generally safe and may have a significant placebo effect. "But I sure wouldn't go out and tell people who don't believe in it to start taking it," Barrett says.

COPYRIGHT 2005 Science Service, Inc.
COPYRIGHT 2005 Gale Group

Return to Common cold
Home Contact Resources Exchange Links ebay